Quote | Awakn Life Sciences (OTCMKTS:AWKNF)
Last: | $0.075 |
---|---|
Change Percent: | -5.06% |
Open: | $0.075 |
Close: | $0.079 |
High: | $0.075 |
Low: | $0.075 |
Volume: | 7,000 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
News | Awakn Life Sciences (OTCMKTS:AWKNF)
2024-05-07 05:54:17 ET More on psychedelic therapies MindMed: Breakthrough Status From FDA For LSD Therapy COMPASS Pathways: Will MDMA-Assisted Therapy Pave The Way? Mind Medicine: GAD Program Success Continues With BTD MindMed releases promising data on LSD-...
Toronto, Ontario--(Newsfile Corp. - May 2, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company"), a clinical-stage biotechnology company developing medication-assisted treatments for addiction with a near-term focus on Alcohol Use Disorder (AUD), annou...
Message Board Posts | Awakn Life Sciences (OTCMKTS:AWKNF)
Subject | By | Source | When |
---|---|---|---|
Huge bids rolling in ;-) | Mr Walnuts | investorshub | 06/17/2022 2:16:16 PM |
Ready for a big day! | Ryguy008 | investorshub | 06/17/2022 2:03:14 PM |
Good Morning $AWKNF | Mr Walnuts | investorshub | 06/17/2022 11:42:36 AM |
Analysts forecasting 1400% upside?? | HighlyLeveraged2 | investorshub | 06/17/2022 4:39:40 AM |
I saw 100k on the bid yesterday .. | Mr Walnuts | investorshub | 06/16/2022 5:04:07 PM |
News, Short Squeeze, Breakout and More Instantly...
Toronto, Ontario--(Newsfile Corp. - May 2, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company"), a clinical-stage biotechnology company developing medication-assisted treatments for addiction with a near-term focus on Alcohol Use Disorder (AUD), annou...
Toronto, Ontario--(Newsfile Corp. - April 17, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company") a clinical-stage biotechnology company developing medication-assisted treatments for addiction with a near-term focus on Alcohol Use Disorder (AUD), is ...
Awakn also announces Private Placement Toronto, Ontario--(Newsfile Corp. - April 3, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company") a clinical-stage biotechnology company developing medication-assisted treatments for addiction with a near-term f...